Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies
Titel:
Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies
Auteur:
Badar, Talha Cortes, Jorge E. Ravandi, Farhad O'Brien, Susan Verstovsek, Srdan Garcia-Manero, Guillermo Kantarjian, Hagop Borthakur, Gautam